NATALIE MITZEL: Open Payments
NPI 1528360583 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 40 payments from 29 companies in 2025. Trend: 2023 $368 · 2024 $1,770 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Stemline Therapeutics Inc. | 2 | $46 |
| Genentech USA, Inc. | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Novocure Inc. | 2 | $34 |
| Genmab U.S., Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| PFIZER INC. | 1 | $26 |
Products named: KISQALI, INJECTAFER, Stivarga, Polivy, ICLUSIG, Tivdak, Vyloy, IBRANCE.
Industry payments across OH — which companies pay providers there.
